Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma.
Saved in:
| Title: | Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma. |
|---|---|
| Authors: | Dhakal B; Department of Medicine, Division of Hematology/Oncology, Medical College of Wisconsin , Milwaukee , WI , USA., Pagenkopf A; Department of Medicine, Division of Hematology-Oncology, University of Wisconsin-Madison , Madison , WI , USA.; University of Wisconsin Carbone Cancer Center , Madison , WI , USA., Mushtaq MU; Department of Medicine, Division of Hematology-Oncology, University of Wisconsin-Madison , Madison , WI , USA.; University of Wisconsin Carbone Cancer Center , Madison , WI , USA., Cunningham AM; Division of Pathology and Laboratory Medicine, Medical College of Wisconsin , Milwaukee , WI , USA., Flietner E; Department of Medicine, Division of Hematology-Oncology, University of Wisconsin-Madison , Madison , WI , USA.; University of Wisconsin Carbone Cancer Center , Madison , WI , USA., Morrow Z; Department of Medicine, Division of Hematology-Oncology, University of Wisconsin-Madison , Madison , WI , USA.; University of Wisconsin Carbone Cancer Center , Madison , WI , USA., Papadas A; Department of Medicine, Division of Hematology-Oncology, University of Wisconsin-Madison , Madison , WI , USA.; University of Wisconsin Carbone Cancer Center , Madison , WI , USA., Hope C; Department of Medicine, Division of Hematology-Oncology, University of Wisconsin-Madison , Madison , WI , USA.; University of Wisconsin Carbone Cancer Center , Madison , WI , USA., Leith C; Division of Pathology and Laboratory Medicine, University of Wisconsin-Madison , Madison , WI , USA., Hematti P; Department of Medicine, Division of Hematology-Oncology, University of Wisconsin-Madison , Madison , WI , USA.; University of Wisconsin Carbone Cancer Center , Madison , WI , USA., Hari P; Department of Medicine, Division of Hematology/Oncology, Medical College of Wisconsin , Milwaukee , WI , USA., Callander NS; Department of Medicine, Division of Hematology-Oncology, University of Wisconsin-Madison , Madison , WI , USA.; University of Wisconsin Carbone Cancer Center , Madison , WI , USA., Asimakopoulos F; Department of Medicine, Division of Hematology-Oncology, University of Wisconsin-Madison , Madison , WI , USA.; University of Wisconsin Carbone Cancer Center , Madison , WI , USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2019 Oct; Vol. 60 (10), pp. 2558-2562. Date of Electronic Publication: 2019 Mar 08. |
| Publication Type: | Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2019.1585836 |
